AHAndrew H. WeiJul 7, 2026New paperautoPaperDurable response to salvage gilteritinib, allogeneic stem cell rescue and maintenance therapy in relapsed AML with a FLT3 N676K variantLeukemia & lymphoma/Leukemia and lymphoma · 2026 · Samuel Grigg, Amit Khot, Andrew H Wei